The store will not work correctly when cookies are disabled.
N-[4-[(1-bromo-2-naphthyl)oxy]-3-chloro-phenyl]-3-hydroxy-benzamide
ID: ALA4751625
PubChem CID: 162653215
Max Phase: Preclinical
Molecular Formula: C23H15BrClNO3
Molecular Weight: 468.73
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccc(Oc2ccc3ccccc3c2Br)c(Cl)c1)c1cccc(O)c1
Standard InChI: InChI=1S/C23H15BrClNO3/c24-22-18-7-2-1-4-14(18)8-10-21(22)29-20-11-9-16(13-19(20)25)26-23(28)15-5-3-6-17(27)12-15/h1-13,27H,(H,26,28)
Standard InChI Key: KFBDORGJTDHYMX-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
16.4596 -27.7977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1679 -27.3827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1631 -26.5565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4540 -26.1531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8813 -27.7927 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5915 -27.3772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3021 -27.7916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0119 -27.3768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0092 -26.5546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2908 -26.1490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5839 -26.5620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3025 -28.6129 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
20.7188 -26.1424 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4328 -26.5473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1425 -26.1350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4371 -27.3686 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.8508 -26.5420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5600 -26.1304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5561 -25.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8372 -24.8994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1351 -25.3175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7441 -27.3845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7495 -26.5657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0470 -26.1538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3346 -26.5563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3292 -27.3751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0362 -27.7915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4621 -28.6149 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
24.2691 -26.5366 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 23 1 0
2 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
7 12 1 0
9 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
15 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 15 1 0
22 23 2 0
22 27 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
1 28 1 0
18 29 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 468.73 | Molecular Weight (Monoisotopic): 466.9924 | AlogP: 7.01 | #Rotatable Bonds: 4 |
Polar Surface Area: 58.56 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 8.77 | CX Basic pKa: ┄ | CX LogP: 6.62 | CX LogD: 6.61 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.34 | Np Likeness Score: -0.92 |
References
1. Fujii S,Kikuchi E,Watanabe Y,Suzuyama H,Ishigami-Yuasa M,Mori T,Isobe K,Uchida S,Kagechika H. (2020) Structural development of N-(4-phenoxyphenyl)benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling., 30 (17): [PMID:32738993] [10.1016/j.bmcl.2020.127408] |